This year was one in which the femtosecond laser and its applications in refractive and cataract surgery and variations in the applications of crosslinking really began to blossom.
Oral fenretinide slowed the growth of geographic atrophy and reduced the incidence of choroidal neovascularization in patients who were treated over a 2-year period with a daily dose of the drug.
Periocular injections of steroids improve active inflammation and macular edema in most patients with uveitis.
A lubricating eye drop product seems to provide ocular relief for an extended period to patients with mild to moderate dry eye.
Although PRK and LASIK caused visual disturbances and dry eye symptoms early after the procedures in a comparison, PRK produced more visual distrubances than LASIK.
A procedure that uses meibomian gland intraductal probing seems to be helpful in patients with severely obstructed meibomian glands.
Patients with moderate to serve dry eye disease are dissatisfied with various dry eye therapies because they do not provide complete symptom relief.
Combination therapy of an anti-platelet-derived growth factor aptamer plus an anti-vascular endothelial lesion regression in 91% of eyes with choroidal neovascularization compared with only 16% of eyes with anti-VEGF monotherapy.
An investigational telescope implant has been given an 8-0 approvable vote by the FDA advisory panel.
An intraoperative wavefront aberrometer seems to be highly beneficial for patients and surgeons because it allows the surgeon to manage astigmatism effectively.